Advertisement

Supportive Care in Cancer

, Volume 28, Issue 2, pp 419–420 | Cite as

Letter to the Editor: Re: “Is heart rate variability a valuable method to investigate cardiac autonomic dysfunction in subjects with leukemia? A systematic review to evaluate its importance in clinical practice” by Kirizawa et al

  • Maxime CaruEmail author
  • Daniel Curnier
Letter to the Editor

Researcher Kirizawa and colleagues recently published a systematic review in the Supportive Care in Cancer on the importance of using heart rate variability (HRV) to investigate cardiac autonomic dysfunction in patients with leukemia [1]. In the light of this study, it seems obvious that HRV will be used in cancer clinical practice, especially because HRV provided valuable information for patients under physiological and pathological conditions. Unfortunately, cardiac autonomic dysfunction is a widely underestimated risk in leukemia patients. With this letter to the editor, we would like to comment on the importance of systematic reviews as a form of evidence in research. We agree with the authors that some questions deserve to be answered regarding leukemia populations to better understand the late adverse effects of cancer and treatments on patients’ cardiac autonomic dysfunction. Moreover, we agree with researchers’ point of view on the importance of HRV in the diagnosis of...

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Kirizawa JM, Garner DM, Arab C, Valenti VE (2019) Is heart rate variability a valuable method to investigate cardiac autonomic dysfunction in subjects with leukemia? A systematic review to evaluate its importance in clinical practice. Support Care Cancer.  https://doi.org/10.1007/s00520-019-05047-x CrossRefGoogle Scholar
  2. 2.
    Higgins JP, Green S (2011) Cochrane handbook for systematic reviews of interventions. WileyGoogle Scholar
  3. 3.
    Caru M, Corbin D, Perie D, Lemay V, Delfrate J, Drouin S et al (2019) Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors. Clin Res Cardiol.  https://doi.org/10.1007/s00392-019-01427-9 CrossRefGoogle Scholar
  4. 4.
    Berger C, Casagranda L, Pichot V, Trombert-Paviot B, Faure-Conter C, Freycon C et al (2018) Dysautonomia in childhood cancer survivors: a widely underestimated risk. J Adolesc Young Adult Oncol.  https://doi.org/10.1089/jayao.2018.0021 CrossRefGoogle Scholar
  5. 5.
    Niederer D, Vogt L, Thiel C, Schmidt K, Bernhorster M, Lungwitz A et al (2013) Exercise effects on HRV in cancer patients. Int J Sports Med 34(1):68–73.  https://doi.org/10.1055/s-0032-1314816 CrossRefPubMedGoogle Scholar
  6. 6.
    Florin TA, Fryer GE, Miyoshi T, Weitzman M, Mertens AC, Hudson MM et al (2007) Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Cancer Epidemiol Biomark Prev 16(7):1356–1363.  https://doi.org/10.1158/1055-9965.Epi-07-0048 CrossRefGoogle Scholar
  7. 7.
    Lipshultz SE, Cochran TR, Franco VI, Miller TL (2013) Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol 10(12):697–710.  https://doi.org/10.1038/nrclinonc.2013.195 CrossRefPubMedGoogle Scholar
  8. 8.
    Faber J, Wingerter A, Neu MA, Henninger N, Eckerle S, Münzel T, Lackner KJ, Beutel ME, Blettner M, Rathmann W, Peters A, Meisinger C, Linkohr B, Neuhauser H, Kaatsch P, Spix C, Schneider A, Merzenich H, Panova-Noeva M, Prochaska JH, Wild PS (2018) Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study. Eur Heart J 39(17):1555–1562.  https://doi.org/10.1093/eurheartj/ehy026 CrossRefPubMedGoogle Scholar
  9. 9.
    Kamath MV, Halton J, Harvey A, Turner-Gomes S, McArthur A, Barr RD (1998) Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhood. Int J Oncol 12(3):635–640PubMedGoogle Scholar
  10. 10.
    Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L et al (2016) Cancer therapy-related cardiac dysfunction and heart failure part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail 9(1):e002661-e.  https://doi.org/10.1161/CIRCHEARTFAILURE.115.002661 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Laboratory of Pathophysiology of EXercise (LPEX), School of Kinesiology and Physical Activity Sciences, Faculty of MedicineUniversity of MontrealMontrealCanada
  2. 2.Sainte-Justine University Health Center, Research CenterMontrealCanada
  3. 3.Laboratoire EA 4430—Clinique Psychanalyse Developpement (CliPsyD), Department of psychologyUniversity of Paris NanterreNanterreFrance

Personalised recommendations